- Home
- INMB vs TACT Comparison
INMB vs TACT Comparison
Compare INMB & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INMB | TACT |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer peripheral equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 58.5M |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | INMB | TACT |
|---|---|---|
| Price | $1.96 | $4.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $5.40 | $5.00 |
| AVG Volume (30 Days) | ★ 326.7K | 12.5K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 11.85 | ★ 87.88 |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $50,000.00 | N/A |
| Revenue This Year | N/A | $10.36 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $71.57 |
| Revenue Growth | ★ 257.14 | N/A |
| 52 Week Low | $1.09 | $3.06 |
| 52 Week High | $2.60 | $6.02 |
Technical Indicators
Market Signals| Indicator | INMB | TACT |
|---|---|---|
| Relative Strength Index (RSI) | 40.57 | 42.76 |
| Support Level | $1.21 | $4.72 |
| Resistance Level | $2.17 | $5.42 |
| Average True Range (ATR) | 0.17 | 0.16 |
| MACD | -0.05 | -0.02 |
| Stochastic Oscillator | 0.00 | 0.00 |
Price Performance
Historical ComparisonAbout INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.